(Reuters) – The U.S. Food and Drug Administration said on Wednesday it authorized state-licensed pharmacists to prescribe Pfizer Inc’s COVID-19 pill, Paxlovid, to eligible patients.
The agency said patients who have tested positive for COVID-19 should bring their health records for the pharmacists to review for kidney and liver problems, and a list of medicines they are currently taking. (https://bit.ly/3Ii4dK6)
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
